Recombinant HP_1331 is a full-length, His-tagged membrane protein derived from Helicobacter pylori, a gram-negative bacterium linked to gastric diseases. Expressed in E. coli, this protein (UniProt ID: O25889) spans 228 amino acids (AA) and is marketed for research applications in microbiology, structural biology, and vaccine development. While its exact biological function remains uncharacterized, its membrane localization suggests potential roles in host-pathogen interactions or bacterial survival mechanisms.
HP_1331 is expressed in E. coli using T7-based vectors, which can induce metabolic stress and inclusion body formation. Key production metrics include:
Challenges in Production:
Recombinant protein synthesis in E. coli often causes growth inhibition due to transcriptional burden and inclusion body formation, particularly for membrane proteins. While HP_1331’s solubility profile is not explicitly described, H. pylori proteins with hydrophobic regions (e.g., transmembrane domains) frequently aggregate under standard conditions .
HP_1331’s uncharacterized status limits direct functional insights, but its classification as a membrane protein suggests roles in:
Pathogen-Host Interactions: H. pylori employs membrane proteins to colonize gastric mucosa and evade immune responses .
Stress Response: H. pylori relies on DNA repair systems (e.g., RuvABC, RecN) for survival under oxidative stress, though HP_1331’s involvement in these pathways remains unconfirmed .
While no peer-reviewed studies directly investigate HP_1331, analogous H. pylori membrane proteins (e.g., adhesins, efflux pumps) are critical for virulence. Further research could explore:
| Area | Potential Focus |
|---|---|
| Structural Analysis | X-ray crystallography or cryo-EM to resolve transmembrane topology |
| Functional Screens | Knockout studies in H. pylori to assess colonization or stress tolerance |
| Vaccine Development | Testing as a candidate antigen for H. pylori subunit vaccines |
KEGG: heo:C694_06870
STRING: 85962.HP1331
HP_1331 is an uncharacterized membrane protein from Helicobacter pylori, a gram-negative, helix-shaped, microaerophilic bacterium belonging to the family Helicobacteraceae. The recombinant form typically encompasses amino acids 1-228 of the native protein. H. pylori was identified in 1982 by Australian scientists Barry Marshall and Robin Warren and is known to colonize the upper gastrointestinal tract of more than 50% of the global population. Infection with H. pylori is associated with a 10-20% lifetime risk of developing peptic ulcers and a 1-2% risk of stomach cancer .
While specific comparative data for HP_1331 is limited, many H. pylori outer membrane proteins (OMPs) belong to the Hop family. These proteins typically fold into anti-parallel amphipathic β-sheets organized into a β-barrel structure, with β-sheet domains localizing to the membrane region. These domains are connected by short amino acid loops in the periplasmic region and longer loops in the extracellular region. HP_1331, as a membrane protein, likely shares some structural similarities with other H. pylori OMPs, though its specific classification and relation to the Hop family requires further characterization .
For recombinant production of HP_1331, researchers can utilize several expression systems including Escherichia coli, yeast, baculovirus, or mammalian cell systems. The choice depends on research objectives and downstream applications. E. coli systems often provide high yields and cost-effectiveness for initial characterization studies, while mammalian expression systems may offer more appropriate post-translational modifications for functional studies. When expressing membrane proteins like HP_1331, specialized E. coli strains (such as C41/C43) and optimized protocols that address protein toxicity and inclusion body formation should be considered .
Purification of membrane proteins like HP_1331 presents significant challenges due to their hydrophobic domains. A methodological approach includes:
Initial extraction using appropriate detergents (e.g., n-dodecyl-β-D-maltoside or CHAPS)
Affinity chromatography utilizing His-tag or other fusion tags
Size exclusion chromatography for further purification
Quality assessment via SDS-PAGE and Western blotting
For HP_1331 specifically, it's worth noting that while the extracellular domains of some H. pylori OMPs have been successfully purified and crystallized, full-length OMPs from H. pylori have proven more challenging to purify in their native conformation .
Given that H. pylori must survive the acidic environment of the stomach, analyzing pH-responsive expression of membrane proteins is crucial. Based on methodologies used for similar H. pylori genes, researchers should consider:
| Experimental Step | Methodology | Key Considerations |
|---|---|---|
| Bacterial Culture | Growth at varying pH (e.g., pH 5.3 vs. neutral) | Use buffered media to maintain stable pH |
| RNA Extraction | TRIzol or column-based methods | Ensure RNase-free conditions |
| Expression Analysis | RNA-seq or RT-qPCR | Include appropriate housekeeping genes as controls |
| Validation | Western blotting | Use specific antibodies against HP_1331 |
| Data Analysis | Calculate fold changes and statistical significance | Apply FDR correction for multiple testing |
This approach has successfully identified numerous pH-responsive genes in H. pylori, as demonstrated in studies examining the ArsRS regulon, where certain membrane proteins showed significant upregulation or downregulation in response to acidic conditions .
For uncharacterized membrane proteins like HP_1331, computational prediction represents a critical first step. A comprehensive bioinformatic analysis should include:
Sequence homology searches using BLAST and HHpred
Transmembrane domain prediction using TMHMM, Phobius, or TOPCONS
Secondary structure prediction via JPred or PSIPRED
Tertiary structure modeling using AlphaFold2 or Rosetta Membrane
Functional domain identification through InterProScan and Pfam
Molecular dynamics simulations to assess stability in membrane environments
When analyzing results, researchers should focus on conserved domains that might suggest functional similarities with characterized proteins, particularly within the context of bacterial membrane proteins involved in pathogenesis.
Determining membrane protein topology is essential for understanding function. For HP_1331, researchers should consider a multi-method approach:
| Method | Technical Approach | Information Gained |
|---|---|---|
| PhoA/LacZ Fusion Analysis | Create reporter fusions at varying positions | Identifies periplasmic vs. cytoplasmic domains |
| Cysteine Scanning Mutagenesis | Systematically replace residues with cysteine | Maps accessible residues |
| Protease Protection Assays | Limited proteolysis of intact cells vs. membrane preparations | Reveals exposed domains |
| Epitope Tagging | Insert epitope tags at predicted loops | Confirms topology through accessibility studies |
| Cryo-EM | Single-particle analysis of purified protein | Provides 3D structural information |
Like many H. pylori OMPs, HP_1331 likely possesses extracellular loops that may be involved in host interactions, periplasmic loops, and membrane-spanning β-sheets arranged in a barrel formation .
While specific functional data for HP_1331 is limited in the provided sources, researchers investigating uncharacterized H. pylori membrane proteins typically examine:
Gene knockout/mutation studies to assess impact on bacterial survival, colonization, and virulence
Pull-down assays to identify interaction partners (both bacterial and host)
Adhesion assays to determine involvement in host cell attachment
Immunological studies to assess immunogenicity and potential as vaccine candidate
pH-responsive expression analysis to understand environmental regulation
Research on other H. pylori OMPs has revealed diverse functions including adhesion to host cells (BabA, SabA, HopQ), enhancement of virulence factor translocation (BabA, HopQ), and roles in inflammatory response induction (OipA) .
Based on known functions of characterized H. pylori membrane proteins, HP_1331 could potentially contribute to pathogenesis through several mechanisms:
Adhesion to gastric epithelial cells or extracellular matrix components
Evasion of host immune responses
Adaptation to the acidic gastric environment
Nutrient acquisition in the restrictive gastric niche
Biofilm formation and bacterial co-aggregation
H. pylori infection leads to a 10-20% lifetime risk of developing peptic ulcers and a 1-2% risk of acquiring stomach cancer. Additionally, H. pylori has been associated with colorectal polyps and colorectal cancer . Understanding the potential role of HP_1331 in these pathogenic processes could provide new insights into disease mechanisms and therapeutic approaches.
Investigating the role of HP_1331 in host-pathogen interactions requires sophisticated methodological approaches:
| Technique | Methodology | Research Application |
|---|---|---|
| Yeast Two-Hybrid | Screen for protein-protein interactions | Identify host cell binding partners |
| Bacterial Two-Hybrid | Test specific protein interactions | Map bacterial protein interactions |
| ELISA-Based Binding Assays | Measure binding to purified host components | Quantify binding affinities |
| Cell Adhesion Assays | Assess attachment to cultured gastric cells | Determine adhesive properties |
| Immunofluorescence Microscopy | Visualize protein localization during infection | Map spatial distribution during infection |
| Animal Infection Models | Compare wild-type vs. HP_1331 mutants | Assess in vivo relevance |
Other H. pylori OMPs such as BabA bind to Lewis B antigens, while SabA interacts with sialyl Lewis X and A antigens. HopQ binds to CEACAM proteins, and AlpA/B interact with extracellular matrix components like collagen IV and laminin . Similar studies with HP_1331 could reveal its specific binding partners and functional roles.
Evaluating HP_1331 as a vaccine candidate involves systematic investigation of several key factors:
Conservation across H. pylori strains to ensure broad protection
Surface exposure and accessibility to antibodies
Immunogenicity and ability to induce protective immune responses
Stability and manufacturability as a recombinant antigen
Efficacy in animal models of H. pylori infection
Recombinant H. pylori proteins are being researched for vaccine development, though it's important to note that such proteins are currently limited to research purposes and cannot be used directly on humans or animals without proper clinical trials and regulatory approval .
Working with membrane proteins like HP_1331 presents several technical challenges that researchers can address through specialized approaches:
Protein aggregation issues: Utilize specialized detergents or nanodiscs to maintain native conformation
Low expression yields: Optimize codon usage and employ specialized expression strains
Purification difficulties: Develop tailored protocols with appropriate detergents and buffer conditions
Structural characterization challenges: Combine multiple techniques (NMR, X-ray crystallography, Cryo-EM)
Functional assay development: Design specific binding and activity assays based on bioinformatic predictions
While the extracellular domains of some H. pylori OMPs have been successfully purified and crystallized, the full-length versions remain challenging. Researchers might consider focusing initially on specific domains of HP_1331 before attempting work with the complete protein .
To investigate correlations between HP_1331 and clinical manifestations, researchers should consider:
Comparative genomics across clinical isolates from different disease states
Transcriptomic analysis of HP_1331 expression in various clinical isolates
Serological studies to assess antibody responses to HP_1331 in patients
Histological examination of HP_1331 expression in gastric biopsies
Correlation analyses between HP_1331 sequence variants and disease severity
H. pylori infections are associated with varying clinical outcomes, from asymptomatic colonization to peptic ulcers and gastric cancer. Understanding the role of specific proteins like HP_1331 in determining these outcomes represents an important research direction .
When faced with conflicting experimental results regarding HP_1331's function, researchers should:
Critically evaluate methodological differences between studies
Consider strain-specific variations in HP_1331 sequence and expression
Assess contextual factors such as growth conditions and experimental models
Design validation experiments using multiple complementary approaches
Perform meta-analyses of available data using standardized criteria
Scientific literature often contains seemingly contradictory results for bacterial membrane proteins, particularly those that are multifunctional or whose activities are context-dependent. A systematic approach to resolving such discrepancies is essential for advancing understanding of HP_1331.
For gene expression studies involving HP_1331, appropriate statistical methods include:
| Statistical Approach | Application | Considerations |
|---|---|---|
| False Discovery Rate (FDR) | Multiple hypothesis testing | Accounts for multiple comparisons |
| Fold Change Analysis | Expression level comparison | Should be combined with statistical significance |
| ANOVA | Comparing multiple conditions | Appropriate for complex experimental designs |
| Correlation Analysis | Identifying co-expressed genes | Helps establish functional relationships |
| Principal Component Analysis | Dimensionality reduction | Reveals patterns in complex datasets |
For example, in pH-responsive gene expression studies, researchers typically calculate both fold changes and FDR-corrected p-values, as seen in studies of other H. pylori genes responding to acidic conditions .